Novel Acylguanidine-Based Inhibitor of HIV-1.

about

In vitro functional assessment of natural HIV-1 group M Vpu sequences using a universal priming approach.Various plus unique: Viral protein U as a plurifunctional protein for HIV-1 replication The chemistry and biology of guanidine natural products.

P2860

Q38730130-C2F750B6-316A-4512-91AE-716944513A2B Q38739273-6F7F9D12-2DE1-49B1-90DF-3326873DADCD Q51175669-9C63A1BB-FDE6-4C56-B7BE-BBA906E29B64

P2860

Novel Acylguanidine-Based Inhibitor of HIV-1.

Item

http://www.wikidata.org/entity/Q38752518

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Novel Acylguanidine-Based Inhibitor of HIV-1.

@en

type

Item

label

Novel Acylguanidine-Based Inhibitor of HIV-1.

@en

prefLabel

Novel Acylguanidine-Based Inhibitor of HIV-1.

@en

P1476

Novel Acylguanidine-Based Inhibitor of HIV-1.

@en

P2093

Aniqa Shahid

http://www.w3.org/2001/XMLSchema#string

Bemuluyigza Baraki

http://www.w3.org/2001/XMLSchema#string

David Fedida

http://www.w3.org/2001/XMLSchema#string

Ian Tietjen

http://www.w3.org/2001/XMLSchema#string

Jonathan Richard

http://www.w3.org/2001/XMLSchema#string

Kyle Cobarrubias

http://www.w3.org/2001/XMLSchema#string

Natalie N Kinloch

http://www.w3.org/2001/XMLSchema#string

Philip Mwimanzi

http://www.w3.org/2001/XMLSchema#string

Scott C Miller

http://www.w3.org/2001/XMLSchema#string

P2860

The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels

Mutual functional destruction of HIV-1 Vpu and host TASK-1 channel

A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif

The HIV-1 Vpu viroporin inhibitor BIT225 does not affect Vpu-mediated tetherin antagonism

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein

Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef.

P304

9495-9508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01107-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mark A. Brockman

Zabrina L Brumme

Andrés Finzi

P577

2016-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27512074

http://www.w3.org/2001/XMLSchema#string

P932

5044834

http://www.w3.org/2001/XMLSchema#string

Novel Acylguanidine-Based Inhibitor of HIV-1.

about

P2860

P2860

Novel Acylguanidine-Based Inhibitor of HIV-1.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932